These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3625484)

  • 1. Influence of urinary pH on the disposition of methoxyphenamine and three metabolites in humans.
    Roy SD; Hawes EM; Midha KK
    J Pharm Sci; 1987 Jun; 76(6):427-32. PubMed ID: 3625484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective in vivo inhibition by quinidine of methoxyphenamine oxidation in rat models of human debrisoquine polymorphism.
    Muralidharan G; Midha KK; McKay G; Hawes EM; Inaba T
    Xenobiotica; 1989 Feb; 19(2):189-97. PubMed ID: 2786289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quinidine but not quinine inhibits in man the oxidative metabolic routes of methoxyphenamine which involve debrisoquine 4-hydroxylase.
    Muralidharan G; Hawes EM; McKay G; Korchinski ED; Midha KK
    Eur J Clin Pharmacol; 1991; 41(5):471-4. PubMed ID: 1761076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enantioselective gas chromatographic assays with electron-capture detection for methoxyphenamine and its three primary metabolites in human urine.
    Srinivas NR; Hubbard JW; Hawes EM; McKay G; Midha KK
    J Chromatogr; 1989 Jan; 487(1):61-72. PubMed ID: 2715275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methoxyphenamine metabolism in rat models of human debrisoquine phenotypes.
    Roy SD; Hawes EM; McKay G; Hubbard JW; Midha KK
    Can J Physiol Pharmacol; 1985 Jul; 63(7):778-81. PubMed ID: 3876145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of methoxyphenamine in extensive and poor metabolizers of debrisoquin.
    Roy SD; Hawes EM; McKay G; Korchinski ED; Midha KK
    Clin Pharmacol Ther; 1985 Aug; 38(2):128-33. PubMed ID: 4017414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of pregnancy on the biotransformation and urinary excretion of methoxyphenamine in mice.
    Foster BC; Wilson DL; Cyr TD; Moffatt J; Buttar HS
    Biopharm Drug Dispos; 1995 Jan; 16(1):1-11. PubMed ID: 7711279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of sparteine and quinidine on the metabolism of methoxyphenamine by Cunninghamella bainieri.
    Foster BC; Wilson DL; McGilveray IJ
    Xenobiotica; 1989 Apr; 19(4):445-52. PubMed ID: 2750204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of in vitro metabolism of methoxyphenamine in rats.
    Roy SD
    Xenobiotica; 1990 Jan; 20(1):55-70. PubMed ID: 2327108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quinine is a more potent inhibitor than quinidine in rat of the oxidative metabolic routes of methoxyphenamine which involve debrisoquine 4-hydroxylase.
    Muralidharan G; Hawes EM; McKay G; Midha KK
    Xenobiotica; 1991 Nov; 21(11):1441-50. PubMed ID: 1763518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic PBPK Modeling of Urine pH Effect on Renal and Systemic Disposition of Methamphetamine and Amphetamine.
    Huang W; Czuba LC; Isoherranen N
    J Pharmacol Exp Ther; 2020 Jun; 373(3):488-501. PubMed ID: 32198137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gas chromatographic quantitation of methoxyphenamine and three of its metabolites in plasma.
    Roy SD; McKay G; Hawes EM; Midha KK
    J Chromatogr; 1984 Oct; 310(2):307-17. PubMed ID: 6150940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of new secondary metabolites of methoxyphenamine in man.
    McKay G; Cooper JK; Hawes EM; Roy SD; Midha KK
    Xenobiotica; 1983 Apr; 13(4):257-64. PubMed ID: 6624141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excretion of methoxyphenamine and its metabolites in rat urine.
    Niwaguchi T; Inoue T
    J Chromatogr; 1978 Nov; 161():223-9. PubMed ID: 730795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of methoxyphenamine in man and in monkey.
    Midha KK; Cooper JK; Mcgilveray IJ; Coutts RT; Dawe R
    Drug Metab Dispos; 1976; 4(6):568-76. PubMed ID: 11979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of methoxyphenamine in vitro by a CYP2D6 microsomal preparation.
    Coutts RT; Bolaji OO; Su P; Baker GB
    Drug Metab Dispos; 1994; 22(5):756-60. PubMed ID: 7835228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of urinary pH on pethidine kinetics in healthy volunteer subjects.
    Chan K; Tse J; Jennings F; Orme ML
    Methods Find Exp Clin Pharmacol; 1985 May; 7(5):245-51. PubMed ID: 4033301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resolution of methoxyphenamine and its analogues on a chiral stationary phase based on (+)-(18-crown-6)-2,3,11,12-tetracarboxylic acid.
    Jeon H; Hyun MH
    J Sep Sci; 2018 Dec; 41(23):4281-4285. PubMed ID: 30267460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of methoxyphenamine and 2-methoxyamphetamine in P4502D6-transfected cells and cell preparations.
    Geertsen S; Foster BC; Wilson DL; Cyr TD; Casley W
    Xenobiotica; 1995 Sep; 25(9):895-906. PubMed ID: 8553683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary profiles of methoxyphenamine and its metabolite after inhalation of methoxyphenamine smoke in humans: aiming to distinguish between active and passive exposure.
    Morinaka H; Kaizaki-Mitsumoto A; Morohoshi H; Uchida N; Numazawa S
    Forensic Toxicol; 2023 Jul; 41(2):230-240. PubMed ID: 36607477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.